Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations
This study is currently recruiting participants.
Verified December 2013 by University of Cincinnati
University of Cincinnati
Merck Sharp & Dohme Corp.
Information provided by (Responsible Party):
Mohamed Tarek Shata, University of Cincinnati
First received: January 20, 2012
Last updated: December 9, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study is currently recruiting participants.|
|Estimated Study Completion Date:||July 2014|
|Estimated Primary Completion Date:||July 2014 (Final data collection date for primary outcome measure)|